These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 4328377)
41. Histocompatibility barriers in human marrow transplantation. Feig SA Am J Pediatr Hematol Oncol; 1980; 2(3):273-80. PubMed ID: 7001944 [No Abstract] [Full Text] [Related]
42. Induction of unresponsiveness to canine renal allografts by total body irradiation and bone marrow transplantation. Rapaport FT; Cannon FD; Blumenstock DA; Watanabe K; Ferrebee JW Nat New Biol; 1972 Feb; 235(58):191-2. PubMed ID: 4551282 [No Abstract] [Full Text] [Related]
43. The use of cyclophosphamide for clinical marrow transplantation. Santos GW; Sensenbrenner LL; Burke PJ; Mullins GM; Blas WB; Tutschka PJ; Slavin RE Transplant Proc; 1972 Dec; 4(4):559-64. PubMed ID: 4405147 [No Abstract] [Full Text] [Related]
44. Toxicity of high-dose busulphan and cyclophosphamide as conditioning therapy for allogeneic bone marrow transplantation in adults with haematological malignancies. Bandini G; Belardinelli A; Rosti G; Calori E; Motta MR; Rizzi S; Benini C; Tura S Bone Marrow Transplant; 1994 May; 13(5):577-81. PubMed ID: 8054910 [TBL] [Abstract][Full Text] [Related]
45. Renal allograft survival in bone marrow chimeras. Hussey JL; Daouk A; Elhabashi S; Kisken WA Surg Forum; 1971; 22():233-5. PubMed ID: 4399270 [No Abstract] [Full Text] [Related]
46. [Unrelated match bone marrow transplantation for severe aplastic anemia]. Urase F; Ishikawa H; Kanbara M; Hazu S; Tsuji K; Ashida T; Tsubaki K; Horiuchi A Rinsho Ketsueki; 1993 Dec; 34(12):1584-6. PubMed ID: 8295334 [TBL] [Abstract][Full Text] [Related]
52. [A method for the quantitative determination of yeasts]. Listemann H; Meigel W Mykosen; 1987 Jun; 30(6):263-70. PubMed ID: 3627164 [No Abstract] [Full Text] [Related]
53. Comparison of the nephrotoxicity of oral neomycin and ampicillin in rats. Narendranathan M; Kurien M; Praseeda I; Balakrishnan V; Varghese S Indian J Gastroenterol; 1982 Apr; 1(1):19-21. PubMed ID: 6927634 [No Abstract] [Full Text] [Related]
54. cis-Dichlorodiammineplatinum(II) (NSC-119 875): preclinical toxicologic evaluation of intravenous injection in dogs, monkeys and mice. Schaeppi U; Heyman IA; Fleischman RW; Rosenkrantz H; Ilievski V; Phelan R; Cooney DA; Davis RD Toxicol Appl Pharmacol; 1973 Jun; 25(2):230-41. PubMed ID: 4197634 [No Abstract] [Full Text] [Related]
55. The effect of oral neomycin and nystatin on fecal flora and prothrombin time. WEISS W; YOSHIZAWA H; EISENBERG GM; FLIPPIN HF Antibiot Chemother (Northfield); 1961 Aug; 11():488-90. PubMed ID: 13784108 [No Abstract] [Full Text] [Related]
56. Collapse after intravenous injection of hashish. Henderson AH; Pugsley DJ Br Med J; 1968 Jul; 3(5612):229-30. PubMed ID: 5662978 [No Abstract] [Full Text] [Related]
57. Amelioration of the side effects of cyclophosphamide. Hussey JL; Kisken WA Surg Forum; 1970; 21():109-11. PubMed ID: 4328377 [No Abstract] [Full Text] [Related]
58. Toxicity of camptothecin (NSC-100880). Schaeppi U; Fleischman RW; Cooney DA Cancer Chemother Rep 3; 1974 Sep; 5(1):25-36. PubMed ID: 4213507 [No Abstract] [Full Text] [Related]
59. Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous busulfan vs oral busulfan in adults conditioned with busulfan + cyclophosphamide for allogeneic bone marrow transplantation. Lee JH; Choi SJ; Lee JH; Kim SE; Park CJ; Chi HS; Lee MS; Lee JS; Kim WK; Lee KH Ann Hematol; 2005 May; 84(5):321-30. PubMed ID: 15580502 [TBL] [Abstract][Full Text] [Related]